Last reviewed · How we verify

NCT05156190: IMPACT

The Impact of Bright Classroom on Myopia

Withdrawn NA Last updated 29 April 2024
What this trial tests

NA trial testing bright classrooms with light level over 1000 lux in Myopia. Withdrawn.

Timeline
1 June 2023
Primary endpoint
30 December 2023
30 December 2023

Quick facts

Lead sponsorQueen's University, Belfast
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Start date1 June 2023
Primary completion30 December 2023
Estimated completion30 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Queen's University, Belfast

Who can join

Adults 7 to 9, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial aims to test the effectiveness and practicality of study in the Bright Classrooms with skylight and artificial light renovation in reducing incident myopia in Chinese primary school children over three years, as compared to children studying in conventional classrooms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Interventions for myopia control in children: a living systematic review and network meta-analysis.
    Lawrenson JG, Shah R, Huntjens B, Downie LE, et al · · 2023 · cited 117× · PMID 36809645 · DOI 10.1002/14651858.cd014758.pub2

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Queen's University, Belfast trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing